Related Experiment Video
Updated: Aug 5, 2025

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
Neutrophils in Mycobacterium tuberculosis
Cheldon Ann Alcantara1, Ira Glassman1, Kevin H Nguyen1
1Department of Basic Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
Neutrophils are key immune responders to Mycobacterium tuberculosis (M. tb) infection, aiding clearance and granuloma formation. Further research is needed on effective tuberculosis vaccination strategies.
Area of Science:
- Immunology
- Infectious Diseases
- Microbiology
Background:
- Mycobacterium tuberculosis (M. tb) remains a major global health threat, particularly in developing nations.
- The Bacillus Calmette-Guérin (BCG) vaccine offers variable protection against M. tb, with efficacy data being equivocal.
- Neutrophils play a critical role in the innate immune response against M. tb.
Purpose of the Study:
- To review and summarize the multifaceted role of neutrophils in M. tb infection.
- To highlight neutrophil functions in both innate and adaptive immunity during tuberculosis.
- To underscore the necessity for improved M. tb vaccination research.
Main Methods:
- Literature review focusing on neutrophil functions in M. tb infection.
- Analysis of current research on BCG vaccine efficacy and limitations.
- Synthesis of data on neutrophil-pathogen interactions and immune modulation.
Main Results:
- Neutrophils are crucial early responders, facilitating M. tb clearance via phagocytosis and granule secretion.
- Neutrophils interact with lymphocytes to orchestrate pro-inflammatory responses and granuloma formation for M. tb containment.
- Existing literature presents conflicting evidence regarding the effectiveness of the BCG vaccine.
Conclusions:
- Neutrophils are indispensable players in the host defense against M. tb.
- The current understanding of neutrophil involvement in tuberculosis highlights potential therapeutic and vaccine targets.
- There is a significant need for continued research into developing more effective tuberculosis vaccines.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bacterial Phylum Actinobacteria
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

